title: Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.
abstract: Congenital uterine anomalies have been associated with poor reproductive outcome, which include recurrent miscarriage, abruptio placenta, intra-uterine growth restriction and preterm delivery. Here, we report a case: 36 years old, G3P2, known case of uterine didelphys, with history of preterm birth, who successfully carried her pregnancy till term with weekly intramuscular injection of 250 mg hydroxyprogesterone caproate (®Proluton Depot, Zuellig Pharma).
authors.forename: Keat Sim
authors.initials: KS
authors.lastname: Ng
authors.forename: Beng Kwang
authors.initials: BK
authors.lastname: Ng
authors.forename: Pei Shan
authors.initials: PS
authors.lastname: Lim
authors.forename: Mohd Nasir
authors.initials: MN
authors.lastname: Shafiee
authors.forename: Abdul Kadir
authors.initials: AK
authors.lastname: Abdul Karim
authors.forename: Mohd Hashim
authors.initials: MH
authors.lastname: Omar
mesh_terms: D000077713:17 alpha-Hydroxyprogesterone Caproate; D000328:Adult; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011256:Pregnancy Outcome; D047928:Premature Birth / Q000517:prevention & control*; D011372:Progestins / Q000627:therapeutic use*; D014564:Urogenital Abnormalities / Q000188:drug therapy*; D014599:Uterus / Q000002:abnormalities*
chemical_list: D006908:Hydroxyprogesterones; D011372:Progestins; D000077713:17 alpha-Hydroxyprogesterone Caproate